Stability-indicating methods for the determination of disopyramide phosphateSALEM, Maissa Y; RAMADAN, Nesrin K; MOUSTAFA, Azza A et al.Journal of AOAC International. 2006, Vol 89, Num 4, pp 976-986, issn 1060-3271, 11 p.Article

Population pharmacokinetic investigation of disopyramide by mixed effect modelling using routine clinical pharmacokinetic data in Japanese patientsYUKAWA, E; ORIO, K; YUKAWA, M et al.Journal of clinical pharmacy and therapeutics (Print). 2005, Vol 30, Num 4, pp 401-405, issn 0269-4727, 5 p.Article

Monitoring Disopyramide, Lidocaine, and Quinidine by Micellar Liquid ChromatographyOCHOA-ARANDA, Enrique; ESTEVE-ROMERO, Josep; RAMBLA-ALEGRE, Maria et al.Journal of AOAC International. 2011, Vol 94, Num 2, pp 537-542, issn 1060-3271, 6 p.Article

FLUORESCENCE PHOTOMETRIC DETERMINATION OF DISOPYRAMIDE AND MONO-N-DEALKYLATED DISOPYRAMIDE IN PLASMA AFTER SEPARATION BY THIN-LAYER CHROMATOGRAPHYGUPTA RN; ENG F; LEWIS D et al.1979; ANAL. CHEM.; USA; DA. 1979; VOL. 51; NO 3; PP. 455-458; BIBL. 10 REF.Article

EFFECT OF PKB ON LIPOPHILIC BINDING OF DISOPYRAMIDE DERIVATIVES TO HUMAN PLASMA. = EFFET DU PK_B SUR LA FIXATION LIPOPHILE DES DERIVES DU DISOPYRAMIDE DU PLASMA HUMAINCHIEN YW; AKERS MJ; YONAN PK et al.1975; J. PHARM. SCI.; U.S.A.; DA. 1975; VOL. 64; NO 10; PP. 1632-1635; BIBL. 5 REF.Article

NATURE OF THE ANTICHOLINERGIC ACTION OF SOME ANTIARRHYTHMIC DRUGS1972; PHARMACOL. RES. COMMUNIC.; G.B.; DA. 1972; VOL. 4; NO 3; PP. 171-178; BIBL. 14REF.Serial Issue

IMPIEGO CLINICO DELLA DISOPIRAMIDE NELLA TERAPIA DELLE ARITMIE CARDIACHE = UTILISATION CLINIQUE DU DISOPYRAMIDE DANS LE TRAITEMENT DES ARYTHMIES CARDIAQUESPELLEGRINO L; DI MICHELE A; PRENCIPE D et al.1973; CLIN. TERAPEUT.; ITAL.; DA. 1973; VOL. 64; NO 4; PP. 323-340; BIBL. 20REF.Serial Issue

SYMPOSIUM ON DISOPYRAMIDE; LONDON; 19751976; J. INTERNATION. MED. RES., SUPPL.; G.B.; DA. 1976; VOL. 4; NO 1; PP. 1-108; BIBL. DISSEM.Conference Paper

SYNCOPES PAR TORSADES DE POINTES EN RAPPORT AVEC LA PRISE DE DISOPYRAMIDE.CASEDEVANT B; SABAUT D; CLEMENTY J et al.1975; NOUV. PRESSE MED.; FR.; DA. 1975; VOL. 4; NO 32; PP. 2339; BIBL. 2 REF.Article

LA REDUCTION DES FIBRILLATIONS AURICULAIRES PAR LE DISOPYRAMIDE1972; COEUR MED. INTERNE; FR.; DA. 1972; VOL. 11; NO 3; PP. 581-586; ABS. ANGL.; BIBL. 26REF.Serial Issue

Determination of disopyramide in human urine by capillary electrophoresis with electrochemiluminescence detection of tris(2,2'-bipyridyl) ruthenium (II)LANYUN FANG; YIN, Xue-Bo; XIUHUA SUN et al.Analytica chimica acta. 2005, Vol 537, Num 1-2, pp 25-30, issn 0003-2670, 6 p.Article

Proceedings/Clinical scope of disopyramide, clinical symposium: 31st. annual meeting of the American College of Angiology, and 21st. annual meeting of the International College of Angiology, San Antonio TX, November 5, 1984WILLIS, P. W. III.Angiology. 1987, Vol 38, Num 2, pp 165-204, issn 0003-3197, 2Conference Proceedings

Acute hepatotoxic effect of disopyramideANTONELLI, D; KOLTUN, B; BARZILAY, J et al.Chest. 1984, Vol 86, Num 2, issn 0012-3692, 274Article

Serum disopyramide concentrations and suppression of ventricular premature contractionsUEDA, C. T; DZINDZIO, B. S; VOSIK, W. M et al.Clinical pharmacology and therapeutics. 1984, Vol 36, Num 3, pp 326-336, issn 0009-9236Article

High-performance liquid chromatography with chemiluminescence detection of disopyramide in human serumCHIBA, R; YAMAMOTO, N; TANAKA, A et al.Analytical sciences. 1998, Vol 14, Num 6, pp 1153-1155, issn 0910-6340Article

Identification of CYP3A4 as the enzyme involved in the mono-N-dealkylation of disopyramide enantiomers in humansECHIZEN, H; TANIZAKI, M; TATSUNO, J et al.Drug metabolism and disposition. 2000, Vol 28, Num 8, pp 937-944, issn 0090-9556Article

Enantioselective binding of disopyramide to α₁-acid glycoprotein and its variantsKISHINO, S; ITOH, S; NAKAGAWA, T et al.European journal of clinical pharmacology. 2001, Vol 57, Num 8, pp 583-587, issn 0031-6970Conference Paper

Stereoselective biliary elimination of disopyramide and mono-N-desisopropyldisopyramide in humansLE CORRE, P; MALLEDANT, Y; CHEVANNE, F et al.Chirality (New-York, NY). 1992, Vol 4, Num 2, pp 80-83, issn 0899-0042Article

A COMPARATIVE STUDY OF DISOPYRAMIDE AND PROCAINAMIDE IN THE TREATMENT OF MYOTONIA IN MYOTONIC DYSTROPHYFINLAY M.1982; J. NEUROL. NEUROSURG. PSYCHIATRY; ISSN 0022-3050; GBR; DA. 1982; VOL. 45; NO 5; PP. 461-463; BIBL. 9 REF.Article

PROPHYLAXIE ET TRAITEMENT DES ARYTHMIES CARDIAQUES PAR LE RYTHMODAN (DISOPYRAMIDE)DOSHSHITSIN VL; GOLOVINA TN; OSIPOVA TN et al.1973; KARDIOLOGIJA; S.S.S.R.; DA. 1973; VOL. 13; NO 3; PP. 97-101; ABS. ANGL.; BIBL. 17 REF.Serial Issue

HYPOGLYCEMIE INDUITE PAR LE DISOPYRAMIDE: UNE OBSERVATIONCHAUSSADE S; BEUCLER A; LAFAIX C et al.1982; NOUV. PRESSE MED.; ISSN 0301-1518; FRA; DA. 1982; VOL. 11; NO 25; PP. 1951; BIBL. 3 REF.Article

LA REDUCTION DES FIBRILLATIONS AURICULAIRES PAR LE DISOPYRAMIDE. 70 TENTATIVESRULLIERE R; VIAL F; PORNIN M et al.1976; NOUV. PRESSE MED.; FR.; DA. 1976; VOL. 5; NO 9; PP. 581-582; BIBL. 18 REF.Article

Factors affecting the binding of disopyramide to serum proteinsSHAW, L. M; ALTMAN, R; THOMPSON, B. C et al.Clinical chemistry (Baltimore, Md.). 1985, Vol 31, Num 4, pp 616-619, issn 0009-9147Article

Differential binding of disopyramide and warfarin enantiomers to human α₁-acid glycoprotein variantsNAKAGAWA, T; KISHINO, S; ITOH, S et al.British journal of clinical pharmacology. 2003, Vol 56, Num 6, pp 664-669, issn 0306-5251, 6 p.Article

Use of silica gel with aqueous eluent for simultaneous high performance liquid chromatographic assay of disopyramide and mono-N-dealkyldisopyramideLONG HAI WANG; KUSHIDA, K; ISHIZAKI, T et al.Therapeutic drug monitoring. 1986, Vol 8, Num 1, pp 85-89, issn 0163-4356Article